MarkRobbinsMD
Cardiology • Nashville, TNAdult Congenital Heart Disease, Interventional Cardiology
Assistant Professor, Medicine, Vanderbilt University School of Medicine
Dr. Robbins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
Cleveland Clinic FoundationFellowship, Interventional Cardiology, 2000 - 2001- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1997 - 1999
University of Mississippi Medical CenterChief Residency, Internal Medicine, 1996 - 1997
Vanderbilt University Medical CenterResidency, Internal Medicine, 1993 - 1996- University of Mississippi School of MedicineClass of 1993
Certifications & Licensure
TN State Medical License 1994 - 2027
KY State Medical License 2001 - 2015
OH State Medical License 2000 - 2001
National Board of Physicians and Surgeons Cardiovascular Disease- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Interventional Cardiology
American Board of Vascular Medicine
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
Publications & Presentations
PubMed
- 156 citationsUltrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.Michel Azizi, Kintur Sanghvi, Manish Saxena, Philippe Gosse, John P. Reilly
Lancet. 2021-06-26 - 81 citationsSix-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedu...Michel Azizi, Roland E. Schmieder, Felix Mahfoud, Michael A. Weber, Joost Daemen
Circulation. 2019-05-28 - 431 citationsEndovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trialMichel Azizi, Roland E. Schmieder, Felix Mahfoud, Michael A. Weber, Joost Daemen
Lancet. 2018-06-09
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
